The strict ban on psychedelic substances has proved to be an obstacle for medical researchers, especially psychopharmacologists, but a recent paper published in The Journal of Nervous and Mental Disease shows that some are making headway. A team led by Swiss psychiatrist Peter Gasser conducted the first controlled trial of LSD in 40 years and concluded that the eight terminally ill patients who received full …
LSD, Reconsidered
